Peiminine is a compound that is isolated from Bolbostemma paniculatum (Maxim) Franquet (Cucurbitaceae family), which has demonstrated antitumor activities. Its precise molecular mechanisms underlying antitumor activity remain elusive. In this study, peiminine-induced apoptosis towards human hepatocellular carcinoma and its molecular mechanisms were investigated. MTT assay was employed to assess anticancer effects of peiminine at concentrations of 2, 4, 6, 8, 10, 12, and 14 µg/ml after 24, 48, or 72 h. Nuclear staining and flow cytometry were carried out to further assess apoptosis. Mitochondrial membrane potential evaluation and Western blot analysis were performed to investigate the mechanism of peiminine-induced apoptosis. Peiminine reduced the viability of HepG2 cells in a time-and dose-dependent manner and had an IC 50 of 4.58 μg/mL at 24h. Flow cytometry assessment indicated that peiminine markedly increased the cell number of apoptotic cells and the mitochondrial membrane potential dose-dependently in HepG2 cells.The results of Western blotting showed the expression of Bcl-2, procaspase-3, procaspase-8, procaspase-9, and PARP 1 decreased in HepG2 cells treated with peiminine, while the expression of Bax, caspase-3, caspase-8, caspase-9, and cleaved PARP 1 increased. The result suggest taht peiminine can induce apoptosis in human hepatocellular carcinoma HepG2 cells through both extrinsic and intrinsic apoptotic pathways .
Introduction
Hepatocellular carcinoma (HCC) ranks third among malignancies related cancer-related deaths, and annually occurs in approximately 600,000 individuals worldwide [1] . Although significant advances in frontline cancer research and chemotherapy have been made in treating HCC, many of the proposed drugs cause potent toxic adverse effects [2] , thereby significantly hampering their usage in the clinic [3] . Hence, there is an unmet need to identify novel chemical compounds with less adverse effects to combat this devastating disease.
Apoptosis is a type of cell death that is characterized by the preservation of plasma membrane integrity, which prevents local inflammatory reactions and tissue damage [4] .
Both intrinsic and extrinsic pathways ultimately converge through the caspase cascade [5] [6] [7] .
Apoptotic cell death has attracted increasing attention for its role in modulating inhibitory activities of anti-neoplastic compounds [8] . Indeed, an increasing number of reports have demonstrated apoptosis induction as the main mechanism for multiple anticancer agents [9] .
Peiminine is a natural compound that is extracted from the bulbs of Fritillaria thunbergii (Liliaceae family) and Bolbostemma paniculatum (Maxim) Franquet (Cucurbitaceae family), and is widely used in traditional Chinese medicine for treating several diseases, including cancer [10] .It has been reported that peiminine repressed colorectal carcinoma tumor growth by inducing autophagic cell death [11] .
However, the role of peiminine on apoptosis in HCC and its underlying mechanism of action remain largely unknown. Hence, the purpose of this study was elucidate the potential molecular mechanism of apoptosis induced by peiminine.
Materials and methods
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Chemicals and reagents
Peiminine which purity is 99.8% was purchased from Pure-one Bio Technology, C O ., LTD. z-DEVD-fmk was purchased from Selleckchem Co., Ltd (Shanghai, China).RPMI-1640 medium, 3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT), propidium iodide (PI), 4,6-diamidino-2-phenylindile(DAPI), dimethyl sulfoxide (DMSO), and anti-Bax, Bcl-2, procaspase-3, -8, -9, caspase-3, -8, -9, PARP 1 (Asp214, 89 kD), PARP 1 (Asp214, 89 kD) cleaved and β-actin primary antibodies were from Sigma-Aldrich Chemical Co., Ltd (Shanghai, China) .
Cell culture
HepG2 cells purchased from the Cell Bank of Type Culture Collection of Chinese Academy of Sciences (Shanghai, China) were grown at 37°C in a 5% CO 2 incubator in RPMI-1640 medium supplemented with 10% (v/v) heat-inactivated fetal bovine serum (FBS), 100 μg/ml streptomycin and 100 U/ml penicillin.
Cell viability assessment
The MTT assay was performed using 1×10 4 HepG2 cells /well in 96-well plates. After culturing for 12h, cells were incubated with peiminine at concentrations of 2, 4, 6, 8, 10, 12, and 14 µg/ml for 24, 48, or 72 h, respectively. Then, 20 μl of MTT solution (5 mg/ml) was added for 4 h, medium was removed, and formazan crystals were dissolved in 150 μl DMSO.
Next, the absorbance was read at 570 nm, and cell viability (%) was determined as follows:
Nuclear staining
HepG2 cells treated with peiminine at the concentration of 4 µg/ml for 24h were fixed 5 with paraformaldehyde at 25°C for 10 min, and then incubated with 20 µl DAPI at a concentration of 10 µg/ml. Nuclear morphology was analyzed using an Olympus FV1000 fluorescence microscope.
Detection of DNA fragmentation
A total of 3 ml cell suspension was plated into 6-well plates (1×10 6 cells/well) and cells were treated with peiminine at concentrations of 0, 2, 4, 6 µg/ml. Cells were lysed after incubation for 24 h. Genomic DNA was extracted using phenol/chloroform/isoamyl alcohol (25: 24: 1), and RNA was removed by RNaseA. For the assay, DNA (30 µg) was separated by 1.5% agarose gel electrophoresis, visualizing DNA fragmentation patterns.
Apoptosis assessment
After treatment of HepG2 cells with peiminine at various amounts for 24 h, apoptosis was evaluated using an Annexin V-FITC kit (BD Co., MA, Ltd, USA) according to the manufacturer's guidelines. Analysis was performed by flow cytometry (BD Bioscience, MA,USA) using the CellQuest software (BDIS).
Cell cycle detection
3 ml HepG2 cell suspension plated into 6-well plates (1×10 6 cells/well) were treated with peiminine at concentrations of 0, 2, 4, 6 µg/ml and incubated in humidified incubator at 37 °C with 5% CO 2 for 24h. Then the cells were harvested and fixed with 70% ethanol overnight, and incubated with 1 ml PI solution (20 μg/ ml in PBS with 1% Triton X-100) containing RNaseA at 37°C away from light for 30 min. Cell cycles were assessed by flow-cytometry (BD Bioscience, MA, USA) with the CellQuest software (BDIS). 6 Mitochondrial membrane potential (MMP) was assessed using the Rhodamine 123 staining approach. 500 μl HepG2 cells (1×10 6 ) were incubated with different amounts of peiminine for 24 h. 10 μl Rhodamine 123 dye (5 g/ ml) was added to cell suspension and cells were incubated in humidified incubator at 37 °C with 5% CO 2 for 30 min. Then the cells were harvested and washed with PBS for 2 times. The fluorescence intensity and cell number were analyzed by flow-cytometry (BD Bioscience, MA, USA). The change of fluorescence intensity indicates the change of mitochondrial membrane potential.
Mitochondrial membrane potential assessment
Determination of caspase activity
After treatment of HepG2 cells with peiminine at concentration of 4 µg/ml or a combination of peiminineat concentration of 4 µg/ml and z-DEVD-fmk at concentration of 10 μmol/L, caspase-3 activities were assessed using a specific colorimetric kit (R&D Systems, Minneapolis, MA, USA) following the manufacturer's instructions. Absorbance was read by spectrophotometry at wavelenghth of 405 nm and caspase activity of caspase-3 was determined.
Intracellular signaling array
Cell lysates were prepared as described above and total proteins were extracted.
Intracellular signaling molecules were determined using a PathScan intracellular signaling array kit (Cell Signaling Technology, MA, USA) according to the manufacturer's instructions.
Western blotting
After treatment of HepG2 cells (1×10 6 ) with 0, 2, 4 and 6 μg/ml of peiminine f or 24h, cell lysates were prepared and centrifuged at 12,000×g for 15 min at 4°C. N 7 ext, the total protein content was extracted from the resulting supernatant and the prot ein concentration was quantified using the bicinchoninic acid(BCA) assay. Equal amo unts (30 μg) of protein were separated by 10% SDS-polyacrylamide gel, and transferr ed onto PVDF membranes. After blocking with TBST containing 5% skimmed milk f or 1h, membranes were incubated overnight at 4°C with rabbit monoclonal anti-human β-actin, procaspase-3, p53, procaspase-8, procaspase-9, Bcl-2, and Bax primary antibod ies, and rabbit polyclonal anti-PARP(Asp214, 89 kD), casepase-3, casepase-8, casepase -9, and cleaved PARP(Asp214, 89 kD) primary antibodies. Then, membranes were wa shed PBS and incubated with horseradish peroxidase (HRP)-conjugated secondary antib odies at 25 °C for 1h. Proteins were visualized using an enhanced chemiluminescence (ECL) kit (Millipore, MA, USA).
Statistical analysis
Data were presented as mean ± standard deviations (SD) from at least three independent experiments. Statistical analysis was performed by One-way ANOVA. p <0.05 was considered statistically significant.Software SPSS 17.0 was used for statistical analysis.
Results
Cytotoxicity of peiminine on HepG2 cells
The cytotoxicity of peiminine on HepG2 cells that were treated with peiminine at various concentrations was assessed by cellular morphology transformations and the MTT method. The results indicated that the cell population treated with peiminine was significantly reduced and exhibited dysmorphic features (Fig. 1A) . In addition, peiminine treatment resulted in a time-and dose-dependent reduction of HepG2 cell viability. IC 50 values of 8 peiminine at 24-, 48-, and 72 h were 4.58 μg/ml, 4.05 μg/ml, and 3.79 μg/ml, respectively.
( Fig. 1B) 
Peiminine-induced apoptosis of HepG2 cells
After treatment of HepG2 cells with peiminine at different concentrations for 24 h, cells were stained with DAPI solution. The results showed chromatin condensation and apoptotic bodies were observed in HepG2 cells that were treated with peiminine ( Fig. 2A ). In addition, the result of DNA fragmentation showed peiminine can dissociated chromosome to produce DNA fragments dose-dependently( Fig. 2B ). As shown in Fig. 2C and Fig. 2D , early apoptotic cells comprised 8.28, 10.32, 15.23, and 19.36 % and late apoptotic cells comprised 3.36, 5.08, 3.55, and 5.51% after treatment of HepG2 cells with peiminine at 0, 2, 4 and 6 μg/ml, respectively.
HepG2 cells arrest at the G2/M phase induced by peiminine
To investigate the mechanism of the growth suppression effect induced by peiminine, cell cycles distribution of HepG2 cells treated with various concentrations of peiminine were assessed by flow cytometer. The results indicated the percentage of G1 phases of HepG2 cells treated with peiminine decreased from 65.15% ±0.78 to 49.55%±0.17 with the increase of concentrations. The percentage of S phases decreased from 25.10% ±0. 52 to 11.68%±0.16
with the increase of concentrations. Meanwhile the percentage of G2/M phases increased from 17.32% ±0.20 to 39.99%±0.47 with the increase of concentrations. (Fig.3) 
Mitochondrial membrane potential reduction induced by peiminine
Mitochondria activate apoptotic cell death by controlling the level of released proapoptotic proteins [12] .They also have important roles in non-apoptotic cell death [13] . In 9 this study, the results showed that the number of living cell treated with peiminine signaficantly decreased ( Fig. 4A ) and mitochondrial membrane potential significantly decreased in a concentration-dependent manner (Fig. 4 B) .
Activity of caspase-3 promoted by peiminine
irreversible inhibitor of Caspase-3/CPP32 [14] . In this study caspase-3 inhibitor was employed to further assess the role of caspase-3 activation in peiminine-treated cells. The results showed that z-DEVD-fmk prevented chromatin condensation of peiminine-treated cells (Fig. 5A ). Moreover, DNA fragmentation also showed that z-DEVD-fmk prevented the occurrence of DNA fragmentation in peiminine-treated cells. Pretreatment of cells with z-DEVD-fmk (50 μM) markedly decreased caspase-3 induction (Fig. 5B) . The activity of caspase-3 in HepG2 cells significantly increased after treatment with peiminine. However, pretreatment of cells with z-DEVD-fmk (50 μM) markedly decreased peiminine-induced caspase-3 activity (Fig.5C ).
Signaling molecules of peiminine-induced apoptosis
To further elucidate the molecular mechanisms of peiminine-induced apoptosis in HepG2 cells, a PathScan intracellular signaling array kit was used to determine the changes of signaling molecules in HepG2 cells before and after peiminine treatment. The data showed that the expression of Bax, cleaved PARP, and Caspase-3,8,9 were significantly up-regulated in peiminine-treated HepG2 cells. In addition, the expression of Bcl-2 and Chk2 were down-regulated in HepG2 cells after treatment with peiminine ( Fig.6 ). 10 To further unveil the mechanism of peiminine-induced apoptosis, various key effectors of programmed cell death were quantitated at the protein level. Caspase-3 is essential for changes observed during apoptosis [15] .Our results showed that the expression of procaspase-3, PARP 1 (Asp214, 89 kD) , procaspases-8 and -9, and Bcl-2 were significantly reduced by 2-6 μg/mL of peiminine treatment. Conversely, caspase-3, 8, 9, PARP 1 (Asp214, 89 kD) cleaved and Bax protein levels were significantly increased upon peiminine treatment.
Effects of peiminine on the expression of apoptotic-related proteins
Discussion
Peiminine is a compound that is isolated from Bolbostemma paniculatum (Maxim) Franquet, and has demonstrated antitumor activities. In the present study, we demonstrated that peiminine markedly inhibited HepG2 cell viability in a time-and dose-dependent manner.
For HepG2 cells, IC 50 values of 4.58 μg/ml, 4.05 μg/ml, and 3.79 μg/ml were obtained at 24, 48, and 72 h, respectively. These results suggested that peiminine has potent cytotoxicity towards HepG2 cells.
Apoptosis contributed to cell homeostasis and several other physiological events [12, 13] .
Two major pathways can activate caspases and apoptosis in mammalians, including the Fas /tumor necrosis factor (TNF) death receptor (extrinsic) and mitochondrial (intrinsic) pathways [15, 16] Anticancer drugs often inhibit tumor cells by inducing apoptosis [18] . As shown above, morphological characteristics of apoptosis were induced by peiminine (Fig. 2) . Quantitation indicated that peiminine treatment resulted in a significant increase in the number of cells in 11 the early apoptosis phase in HepG2 cells. We examined the mitochondrial membrane potential to assess whether peiminine-induced apoptosis involved the intrinsic pathway.
Indeed, peiminine treatment resulted in significantly decreased mitochondrial membrane potential.
Caspase activation results in apoptotic cell death due to death signals from cell-surface receptors, mitochondria, or the endoplasmatic reticulum (ER) [19] , with caspase-3 mainly initiating apoptosis [20] . Caspase-3 activation is induced by initiator caspases, e.g. caspase-8 or -9 [21] .In this study, the potent caspase-3 inhibitor z-DEVD-fmk inhibited chromatin condensation in peiminine-treated cells, and attenuated caspase-3 activation.
The Bcl-2 family of proteins mainly controls the intrinsic apoptotic pathway [22] , which includes pro-and anti-apoptotic effectors that are induced or inhibited according to the heterodimerization pattern [23] . In this study, we showed that peiminine treatment resulted in increased Bax levels and decreased Bcl-2 levels, thereby shifting the balance towards enhanced apoptosis. Additionally, the the expression of procaspase-3, PARP, procaspases-8 and -9, and Bcl-2 were significantly reduced by 2-6 μg/mL of peiminine treatment.
Conversely, caspase-3, 8, 9, and Bax protein levels were significantly increased upon peiminine treatment.
In conclusion, peiminine displayed significant cytotoxicity in HepG2 cells and markedly increased the number of cells in the early apoptosis phase. Both extrinsic and intrinsic apoptotic pathways were triggered by peiminine, suggesting that peiminine may be considered as a potential drug candidate for liver cancer treatment. 
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